Cargando…

Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties

BACKGROUND: Autoreactive Th1 and Th17 cells are believed to mediate the pathology of multiple sclerosis in the central nervous system (CNS). Their interaction with microglia and astrocytes in the CNS is crucial for the regulation of the neuroinflammation. Previously, we have shown that only Th1 but...

Descripción completa

Detalles Bibliográficos
Autores principales: Prajeeth, Chittappen K., Kronisch, Julius, Khorooshi, Reza, Knier, Benjamin, Toft-Hansen, Henrik, Gudi, Viktoria, Floess, Stefan, Huehn, Jochen, Owens, Trevor, Korn, Thomas, Stangel, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644084/
https://www.ncbi.nlm.nih.gov/pubmed/29037246
http://dx.doi.org/10.1186/s12974-017-0978-3
_version_ 1783271661255000064
author Prajeeth, Chittappen K.
Kronisch, Julius
Khorooshi, Reza
Knier, Benjamin
Toft-Hansen, Henrik
Gudi, Viktoria
Floess, Stefan
Huehn, Jochen
Owens, Trevor
Korn, Thomas
Stangel, Martin
author_facet Prajeeth, Chittappen K.
Kronisch, Julius
Khorooshi, Reza
Knier, Benjamin
Toft-Hansen, Henrik
Gudi, Viktoria
Floess, Stefan
Huehn, Jochen
Owens, Trevor
Korn, Thomas
Stangel, Martin
author_sort Prajeeth, Chittappen K.
collection PubMed
description BACKGROUND: Autoreactive Th1 and Th17 cells are believed to mediate the pathology of multiple sclerosis in the central nervous system (CNS). Their interaction with microglia and astrocytes in the CNS is crucial for the regulation of the neuroinflammation. Previously, we have shown that only Th1 but not Th17 effectors activate microglia. However, it is not clear which cells are targets of Th17 effectors in the CNS. METHODS: To understand the effects driven by Th17 cells in the CNS, we induced experimental autoimmune encephalomyelitis in wild-type mice and CD4(+) T cell-specific integrin α4-deficient mice where trafficking of Th1 cells into the CNS was affected. We compared microglial and astrocyte response in the brain and spinal cord of these mice. We further treated astrocytes with supernatants from highly pure Th1 and Th17 cultures and assessed the messenger RNA expression of neurotrophic factors, cytokines and chemokines, using real-time PCR. Data obtained was analyzed using the Kruskal-Wallis test. RESULTS: We observed in α4-deficient mice weak microglial activation but comparable astrogliosis to that of wild-type mice in the regions of the brain populated with Th17 infiltrates, suggesting that Th17 cells target astrocytes and not microglia. In vitro, in response to supernatants from Th1 and Th17 cultures, astrocytes showed altered expression of neurotrophic factors, pro-inflammatory cytokines and chemokines. Furthermore, increased expression of chemokines in Th1- and Th17-treated astrocytes enhanced recruitment of microglia and transendothelial migration of Th17 cells in vitro. CONCLUSION: Our results demonstrate the delicate interaction between T cell subsets and glial cells and how they communicate to mediate their effects. Effectors of Th1 act on both microglia and astrocytes whereas Th17 effectors preferentially target astrocytes to promote neuroinflammation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-017-0978-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5644084
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56440842017-10-18 Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties Prajeeth, Chittappen K. Kronisch, Julius Khorooshi, Reza Knier, Benjamin Toft-Hansen, Henrik Gudi, Viktoria Floess, Stefan Huehn, Jochen Owens, Trevor Korn, Thomas Stangel, Martin J Neuroinflammation Research BACKGROUND: Autoreactive Th1 and Th17 cells are believed to mediate the pathology of multiple sclerosis in the central nervous system (CNS). Their interaction with microglia and astrocytes in the CNS is crucial for the regulation of the neuroinflammation. Previously, we have shown that only Th1 but not Th17 effectors activate microglia. However, it is not clear which cells are targets of Th17 effectors in the CNS. METHODS: To understand the effects driven by Th17 cells in the CNS, we induced experimental autoimmune encephalomyelitis in wild-type mice and CD4(+) T cell-specific integrin α4-deficient mice where trafficking of Th1 cells into the CNS was affected. We compared microglial and astrocyte response in the brain and spinal cord of these mice. We further treated astrocytes with supernatants from highly pure Th1 and Th17 cultures and assessed the messenger RNA expression of neurotrophic factors, cytokines and chemokines, using real-time PCR. Data obtained was analyzed using the Kruskal-Wallis test. RESULTS: We observed in α4-deficient mice weak microglial activation but comparable astrogliosis to that of wild-type mice in the regions of the brain populated with Th17 infiltrates, suggesting that Th17 cells target astrocytes and not microglia. In vitro, in response to supernatants from Th1 and Th17 cultures, astrocytes showed altered expression of neurotrophic factors, pro-inflammatory cytokines and chemokines. Furthermore, increased expression of chemokines in Th1- and Th17-treated astrocytes enhanced recruitment of microglia and transendothelial migration of Th17 cells in vitro. CONCLUSION: Our results demonstrate the delicate interaction between T cell subsets and glial cells and how they communicate to mediate their effects. Effectors of Th1 act on both microglia and astrocytes whereas Th17 effectors preferentially target astrocytes to promote neuroinflammation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-017-0978-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-16 /pmc/articles/PMC5644084/ /pubmed/29037246 http://dx.doi.org/10.1186/s12974-017-0978-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Prajeeth, Chittappen K.
Kronisch, Julius
Khorooshi, Reza
Knier, Benjamin
Toft-Hansen, Henrik
Gudi, Viktoria
Floess, Stefan
Huehn, Jochen
Owens, Trevor
Korn, Thomas
Stangel, Martin
Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
title Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
title_full Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
title_fullStr Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
title_full_unstemmed Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
title_short Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
title_sort effectors of th1 and th17 cells act on astrocytes and augment their neuroinflammatory properties
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644084/
https://www.ncbi.nlm.nih.gov/pubmed/29037246
http://dx.doi.org/10.1186/s12974-017-0978-3
work_keys_str_mv AT prajeethchittappenk effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties
AT kronischjulius effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties
AT khorooshireza effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties
AT knierbenjamin effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties
AT tofthansenhenrik effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties
AT gudiviktoria effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties
AT floessstefan effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties
AT huehnjochen effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties
AT owenstrevor effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties
AT kornthomas effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties
AT stangelmartin effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties